Original Article

Eosinophilia and Associated Factors in a Large Cohort of Patients Infected with Human Immunodeficiency Virus

Authors: Mayar Al Mohajer, MD, Erick Villarreal-Williams, MD, Roberto A. Andrade, MD, Thomas P. Giordano, MD, MPH, Jose A. Serpa, MD, MS

Abstract

Objectives: To determine the prevalence of eosinophilia among antiretroviral therapy (ART)–naïve patients infected with human immunodeficiency virus (HIV) and to identify variables associated with eosinophilia.

Methods: We included all ART-naïve HIV-infected patients entering into care at the Thomas Street Health Center (Houston, Texas) between February 2007 and January 2009. Eosinophilia was defined as absolute eosinophil count ≥400 cells per cubic millimeter. Patients with eosinophilia (cases) at baseline were matched to patients without baseline eosinophilia (controls). Clinical and laboratory data were collected for cases and controls. Variables associated with eosinophilia were evaluated by univariate and multivariate analyses.

Results: Sixty-five (9.7%) of 671 ART-naïve patients had eosinophilia. There was no difference in age, sex, race, or baseline CD4 count between patients with and without eosinophilia; however, patients with eosinophilia were more likely to have higher HIV RNA viral loads (5.05 vs 4.82 log 10 copies per milliliter; P = 0.019). A total of 52 (80%) of 65 patients with eosinophilia (cases) had at least two follow-up clinic visits. They were matched to 104 controls. Skin rash was the only variable associated with eosinophilia (odds ratio 2.16, 95% confidence interval 1.04–4.47) in our multivariate analysis. Of eight cases tested, only one, from Central America, had a parasitic infection (hookworm). Thirty-eight (73.1%) patients experienced resolution of their eosinophilia by the end of the study (mean follow-up 1019 days). Resolution of eosinophilia did not differ between patients with and without HIV viral suppression.

Conclusions: Eosinophilia is not an infrequent occurrence among ART-naïve HIV-infected patients. Patients with eosinophilia are more likely than patients without eosinophilia to present with a skin rash. HIV RNA viral suppression did not necessarily result in the resolution of eosinophilia. Extensive workup for eosinophilia may not be necessary in most cases.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-1600.
 
2. Tefferi A. Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment. Mayo Clin Proc 2005;80:75-83.
 
3. Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 2010;126:39-44.
 
4. Sivaram M, White A, Radcliffe KW. Eosinophilia: clinical significance in HIV-infected individuals. Int J STD AIDS 2012;23:635-638.
 
5. Caterino-de-Araujo A. HIV-1 infection and eosinophilia. Immunol Today 1994;15:498-499.
 
6. van der Graaf W, Borleffs JC. Eosinophilia in patients with HIV-1 infection. Eur J Haematol 1994;52:246-247.
 
7. Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 1996;174:615-618.
 
8. Sanchez-Borges M, Orozco A, Di Biagio E, et al. Eosinophilia in early-stage human immunodeficiency virus infection. J Allergy Clin Immunol 1993;92:494-495.
 
9. Tietz A, Sponagel L, Erb P, et al. Eosinophilia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1997;16:675-677.
 
10. Marinacci G, Brighi S, Ricchi E, et al. Adrenal insufficiency and acquired immunodeficiency syndrome (abstract no. PO-B25-1969). In: Program and Abstracts of the IX International AIDS Conference; Berlin, Germany; June 6-11, 1993: 463.
 
11. Paganelli R, Scala E, Mezzaroma I, et al. Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol 1995;95(5 Pt 1):995-1003.
 
12. Drabick JJ, Magill AJ, Smith KJ, et al. Hypereosinophilic syndrome associated with HIV infection. Military Medical Consortium for Applied Retroviral Research. South Med J 1994;87:525-529.
 
13. Skiest DJ, Keiser P. Clinical significance of eosinophilia in HIV-infected individuals. Am J Med 1997;102:449-453.
 
14. Adewuyi JO, Coutts AM, Latif AS, et al. Haematologic features of the human immunodeficiency virus (HIV) infection in adult Zimbabweans. Cent Afr J Med 1999;45:26-30.